-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Initiates Coverage On Arrowhead Pharma with Buy Rating, Announces Price Target of $98

Benzinga·07/14/2026 09:54:32
Listen to the news
Stifel analyst James Condulis initiates coverage on Arrowhead Pharma (NASDAQ:ARWR) with a Buy rating and announces Price Target of $98.